Neurocrine Bioscience buy Citigroup Inc.
Start price
21:00
/
50%
€103.35
Target price
12.02.27
€171.73
Performance (%)
0.34%
Price
22:26
€103.70
Summary
This prediction is currently active. Since the start of the prediction for Neurocrine Bioscience the price has only changed by 0.34%. This prediction currently runs until 12.02.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Neurocrine Bioscience | 0.34% |
| iShares Core DAX® | 1,30 % |
| iShares Nasdaq 100 | 0,61 % |
| iShares Nikkei 225® | 8,77 % |
| iShares S&P 500 | 0,25 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target raised by analysts at Citigroup Inc. from $203.00 to $204.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€117.75
29.10.25
29.10.25
€174.28
29.10.26
29.10.26
-11.93%
22:26
22:26
